Giuseppe Vergaro

giuseppe.vergaro@santannapisa.it
050 883741
Complesso edilizio Sede Centrale

Pubblicazioni

Cappelli, F.; Tini, G.; Russo, D.; Emdin, M.; Del Franco, A.; Vergaro, G.; Di Bella, G.; Mazzeo, A.; Canepa, M.; Volpe, M.; Perfetto, F.; Autore, C.; Di Mario, C.; Rapezzi, C.; Musumeci, M. B.

Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation Open new browser tab

(2021)
Emdin, M.; Perfetto, F.; Aimo, A.; Vergaro, G.; Buda, G.; Cappelli, F.; Pieroni, M.; Grippo, G.; Sorini Dini, C.; Canale, M. L.; Olivotto, I.; Cameli, M.; Casolo, G.

Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) Open new browser tab

(2021)
Aimo, Alberto; Rapezzi, Claudio; Vergaro, Giuseppe; Giannoni, Alberto; Spini, Valentina; Passino, Claudio; Emdin, Michele

Management of complications of cardiac amyloidosis: 10 questions and answers Open new browser tab

(2021)
Vergaro, G.; Castiglione, V.; Aimo, A.; Prontera, C.; Musetti, V.; Masotti, S.; Giannelli, E.; Maltinti, M.; Passino, C.; Emdin, M.

Biomarkers for the diagnosis and management of heart failure: New frontiers Open new browser tab

(2021)
Vergaro, G.; Aimo, A.; Campora, A.; Castiglione, V.; Prontera, C.; Masotti, S.; Musetti, V.; Chianca, M.; Valleggi, A.; Spini, V.; Emdin, M.; Passino, C.

Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure Open new browser tab

(2021)
Del Franco, Annamaria; Ambrosio, Giuseppe; Baroncelli, Laura; Pizzorusso, Tommaso; Barison, Andrea; Olivotto, Iacopo; Recchia, FABIO ANASTASIO; Lombardi, Carlo M.; Metra, Marco; Ferrari Chen, Yu F.; Passino, Claudio; Emdin, Michele; Vergaro, Giuseppe

Creatine deficiency and heart failure Open new browser tab

(2021)
Aimo, A.; Rapezzi, C.; Arzilli, C.; Vergaro, G.; Emdin, M.

Safety and efficacy of levosimendan in patients with cardiac amyloidosis Open new browser tab

(2020)
Lubrano, V.; Vergaro, G.; Maltinti, M.; Ghionzoli, N.; Emdin, M.; Papa, A.

α-1 Antitrypsin as a potential biomarker in chronic heart failure Open new browser tab

(2020)
Emdin, M.; Aimo, A.; Castiglione, V.; Vergaro, G.; Georgiopoulos, G.; Saccaro, L. F.; Lombardi, C. M.; Passino, C.; Cerbai, E.; Metra, M.; Senni, M.

Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week Open new browser tab

(2020)
Martini, N.; Aimo, A.; Barison, A.; Della Latta, D.; Vergaro, G.; Aquaro, G. D.; Ripoli, A.; Emdin, M.; Chiappino, D.

Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance Open new browser tab

(2020)

Giuseppe Vergaro

Pubblicazioni

Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation Open new browser tab

Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) Open new browser tab

Management of complications of cardiac amyloidosis: 10 questions and answers Open new browser tab

Biomarkers for the diagnosis and management of heart failure: New frontiers Open new browser tab

Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure Open new browser tab

Creatine deficiency and heart failure Open new browser tab

Safety and efficacy of levosimendan in patients with cardiac amyloidosis Open new browser tab

α-1 Antitrypsin as a potential biomarker in chronic heart failure Open new browser tab

Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week Open new browser tab

Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance Open new browser tab

Corsi

News